TA
TLS Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-259
| Closed | -$272K | – | 19 |
|
|
2024
Q3 | $272K | Buy |
259
+9
| +4% | +$9.45K | 0.57% | 15 |
|
|
2024
Q2 | $263K | Hold |
250
| – | – | 0.66% | 15 |
|
|
2024
Q1 | $240K | Hold |
250
| – | – | 0.56% | 13 |
|
|
2023
Q4 | $220K | Hold |
250
| – | – | 0.73% | 13 |
|
|
2023
Q3 | $205K | Buy |
+250
| New | +$205K | 0.83% | 13 |
|
|
2023
Q2 | – | Sell |
-250
| Closed | -$205K | – | 17 |
|
|
2023
Q1 | $205K | Hold |
250
| – | – | 1.05% | 13 |
|
|
2022
Q4 | $180K | Buy |
+250
| New | +$180K | 0.89% | 16 |
|